499 results on '"Willis, Allison W"'
Search Results
2. Genetic and phenotypic characterization of Parkinson’s disease at the clinic-wide level
3. Channeling of New Neuropsychiatric Drugs—Impact on Safety and Effectiveness Studies
4. Comparative safety of antimuscarinics versus mirabegron for overactive bladder in Parkinson disease
5. Potentially inappropriate medications in older adults with Parkinson disease before and after hospitalization for injury
6. Hallucinations, Antipsychotic Use, and Mortality in Older Adults with Dementia: Retrospective Cohort Study of Two Medicare-Linked National Health Surveys
7. Selected autonomic signs and symptoms as risk markers for phenoconversion and functional dependence in prodromal Parkinson’s disease
8. Gender disparities in deep brain stimulation surgery for Parkinson disease and essential tremor
9. Thinking Three‐Dimensionally: A Self‐ and Externally‐Controlled Approach to Screening for Drug–Drug–Drug Interactions Among High‐Risk Populations
10. Self-reported Visual Difficulty, Age-related Eye Disease, and Neuropsychiatric Outcomes in Older Adults
11. Atypical antipsychotic use and mortality risk in Parkinson disease
12. Medicare Claims Data Underestimate Hallucinations in Older Adults With Dementia
13. Comparative risk of serious hypoglycemia among persons dispensed a fluoroquinolone versus a non-fluoroquinolone antibiotic
14. Application of High-Dimensional Propensity Score Methods to the National Health and Aging Trends Study.
15. Direct-Acting Oral Anticoagulants and Antiseizure Medications for Atrial Fibrillation and Epilepsy and Risk of Thromboembolic Events.
16. Non-Ergot Dopamine Agonists and the Risk of Heart Failure and Other Adverse Cardiovascular Reactions in Parkinson's Disease.
17. Abstract 98: Direct-Acting Oral Anticoagulants and Antiseizure Medications for Atrial Fibrillation and Epilepsy: Risk of Thromboembolic and Major Bleeding Events
18. Statins for the Prevention of Post-Stroke Seizure and Epilepsy Development: A Systematic Review and Meta-Analysis
19. A nationwide analysis of maternal morbidity and acute postpartum readmissions in women with epilepsy
20. National randomized controlled trial of virtual house calls for Parkinson disease
21. Annual Prevalence of Use of Potentially Inappropriate Medications for Treatment of Affective Disorders in Parkinson's Disease
22. Interaction between visual impairment and genetic risk of dementia and psychosis in older adults.
23. Inpatient gastrostomy in Huntington's disease: Nationwide analysis of utilization and outcomes compared to amyotrophic lateral sclerosis
24. Acute readmission following deep brain stimulation surgery for Parkinson's disease: A nationwide analysis
25. Molecular Integration in Neurological Diagnosis (MIND) Parkinson's Disease Inception Cohort Study Protocol
26. National Randomized Controlled Trial of Virtual House Calls for People with Parkinson's Disease: Interest and Barriers
27. Nationwide emergency department visits for pediatric traumatic spinal cord injury in the United States, 2016–2020
28. Low continuation of antipsychotic therapy in Parkinson disease – intolerance, ineffectiveness, or inertia?
29. Understanding nationwide readmissions after thyroid surgery
30. Impact of ICD-9 to ICD-10 Coding Transition on Prevalence Trends in Neurology
31. Unique characteristics of end-of-life hospitalizations in Parkinson disease
32. Health equity integrated epilepsy care and research: A narrative review
33. Readmissions After Mechanical Thrombectomy for Acute Ischemic Stroke in the United States: A Nationwide Analysis
34. Sex disparities in health and health care utilization after Parkinson diagnosis: Rethinking PD associated disability
35. Predictors of Mortality in Older Adults With Epilepsy: Implications for Learning Health Systems
36. Sociodemographic and Geographic Disparities in End-of-Life Health Care Intensity Among Medicare Beneficiaries With Parkinson Disease
37. The Water, the Air, the Marines—Camp Lejeune, Trichloroethylene, and Parkinson Disease
38. State-level prevalence, health service use, and spending vary widely among Medicare beneficiaries with Parkinson disease
39. Comorbid disease drives short-term hospitalization outcomes in patients with multiple sclerosis
40. Change In Fall Risk-Increasing Drug Use Among Individuals with Parkinson Disease Before and After a Serious Injury (P2-5.032)
41. Racial and Ethnic Disparities in Parkinson Disease
42. Dopamine agonists and risk of lung cancer in patients with restless legs syndrome
43. Functional Impairment in Individuals With Prodromal or Unrecognized Parkinson Disease
44. Readmission after seizure discharge in a nationally representative sample
45. Continuous EEG is associated with favorable hospitalization outcomes for critically ill patients
46. Nationwide trends in emergency department utilisation for acute retinal ischaemia in the USA, 2011–2018.
47. Adjusting for Underrepresentation Reveals Widespread Underestimation of Parkinson's Disease Symptom Burden.
48. Association between medication-related adverse events and non-elective readmission in acute ischemic stroke
49. Seasonal Variation in Neurologic Hospitalizations in the United States
50. Interfacility Transfers for Seizure-Related Emergencies in the United States
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.